表紙
市場調査レポート

血行動態モニタリングシステムの世界市場の予測 〜2021年:製品・タイプ・エンドユーザー別

Hemodynamic Monitoring Systems Market by Product (Systems, & Disposables), Type (Invasive, Minimally invasive, & Non-invasive), End User (Hospitals, Cath labs, & Home and Ambulatory Care) - Global Forecasts to 2021

発行 MarketsandMarkets 商品コード 325609
出版日 ページ情報 英文 137 Pages
即納可能
価格
本日の銀行送金レート: 1USD=104.18円で換算しております。
Back to Top
血行動態モニタリングシステムの世界市場の予測 〜2021年:製品・タイプ・エンドユーザー別 Hemodynamic Monitoring Systems Market by Product (Systems, & Disposables), Type (Invasive, Minimally invasive, & Non-invasive), End User (Hospitals, Cath labs, & Home and Ambulatory Care) - Global Forecasts to 2021
出版日: 2016年08月15日 ページ情報: 英文 137 Pages
概要

世界の血行動態モニタリングシステムの市場規模は、2016年には9億2520万米ドル、2021年には11億4370万米ドルと、4.3%のCAGR (複合年間成長率) で増加する見通しです。市場成長の主な要因として、糖尿病・心血管疾患の患者数の増加や技術進歩、業界関係者の積極的な取り組み、高齢者人口の増加などが挙げられます。システム (装置) 市場を詳細に見てみると、侵襲的システムが集中治療室 (ICU)・手術室 (OT) 向けを中心に、まだ市場の大半を占めています。

当レポートでは、世界の血行動態モニタリングシステムの市場について調査し、市場背景および市場構造、製品タイプの種類と概要、製品区分・タイプ・エンドユーザー別の市場規模の推移と予測、地域別の動向、市場成長への各種影響因子の分析、競合環境と市場シェア、主要企業のプロファイルなどをまとめています。

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 血行動態モニタリングシステムの世界市場:概要

  • イントロダクション
  • 市場区分
  • 市場力学
    • 市場成長推進因子
      • 血行動態モニタリングシステムの技術進歩
        • 非侵襲的血行動態モニタリングシステム
        • MEMS (微小電気機械システム) 技術
      • 企業側の積極的な取り組み
      • 心血管疾患・糖尿病の有病者数の増加
      • 高齢者人口の急速な増加
    • 市場成長阻害因子
      • 侵襲的血行動態モニタリングシステム関連のリスク
    • 市場機会
      • インドと中国が巨大な市場成長機会を提供

第6章 血行動態モニタリングシステムの世界市場:製品別

  • イントロダクション
  • システム (モニター)
  • 消耗品

第7章 血行動態モニタリングシステムの世界市場:タイプ別

  • イントロダクション
  • 侵襲的血行動態モニタリングシステム
  • 低侵襲的血行動態モニタリングシステム
  • 非侵襲的血行動態モニタリングシステム

第8章 血行動態モニタリングシステムの世界市場:エンドユーザー別

  • イントロダクション
  • 病院
  • カテーテル室
  • 自宅・外来診療所

第9章 血行動態モニタリングシステムの世界市場:地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 欧州主要5ヶ国 (フランス・ドイツ・イタリア・スペイン・英国)
    • その他 (オランダ・スウェーデンなど)
  • アジア太平洋地域
    • 日本
    • 中国
    • インド
    • その他 (ベトナム・シンガポール・マレーシア・台湾など)
  • 他の国々 (RoW:ブラジル、中東・アフリカなど)

第10章 競合環境

  • 概要
  • 競合状況・動向
  • 市場シェア分析
    • イントロダクション
    • EDWARDS LIFESCIENCES CORPORATION
    • PULSION MEDICAL SYSTEMS SE
    • LIDCO GROUP PLC.
  • 競合シナリオ
    • 協定・事業協力・合弁事業
    • 製品発売
    • 企業合併・買収 (M&A)
    • その他の戦略

第11章 企業プロファイル

  • EDWARDS LIFESCIENCES CORPORATION
  • PULSION MEDICAL SYSTEMS SE (THE MAQUET GETINGE GROUPの一部)
  • LIDCO GROUP PLC
  • CHEETAH MEDICAL, INC.
  • DELTEX MEDICAL GROUP PLC
  • HEMO SAPIENS, INC.
  • ICU MEDICAL, INC.
  • OSYPKA MEDICAL GMBH
  • SCHWARZER CARDIOTEK GMBH
  • TENSYS MEDICAL, INC.

第12章 付録

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MD 3211

The hemodynamic monitoring systems market is projected to reach USD 1,143.7 million by 2021 from USD 925.2 million in 2016, growing at a CAGR of 4.3% during the forecast period. Factors such as rising prevalence of diabetes and cardiovascular diseases, technological advancements, initiatives adopted by industry players, and rising aging population are driving the growth of the hemodynamic monitoring systems market.

Hemodynamic monitoring is the measurement of blood circulation and cardiac functions. It allows doctors to evaluate whether enough oxygen is being delivered to the organs and tissues. Healthcare providers use this information to detect changes or problems in a patient's health.

The disposables segment is expected to account for the largest share of the hemodynamic monitoring systems market, by product, in 2016. Hemodynamic disposables form an integral part of hemodynamic monitoring to determine the hemodynamic parameters in critically ill patients, thus attributing to the large share of the segment.

The invasive monitoring systems segment is expected to account for the largest share of the hemodynamic monitoring systems market, by type, in 2016. The large share of this segment is mainly attributed to the increasing utilization of invasive hemodynamic monitoring systems in both intensive care units (ICUs) and operating theaters (OTs) for the monitoring of patients with critical illnesses and hemodynamic instability.

The hospitals segment is expected to account for the largest share of the global hemodynamic monitoring systems market, by end user, in 2016. The large share of this segment is mainly attributed to the rising aging population and increasing prevalence of diseases such as cardiovascular and diabetes.

North America is expected to account for the largest share of the hemodynamic monitoring systems market in 2016, followed by Asia-Pacific, Europe, and the Rest of the World (RoW). The large share of the North American region can be attributed to technological advancements, initiatives adopted by industry players to boost the demand of hemodynamic monitoring systems in the U.S., and prevalence of high diabetes in Canada propels the market for Hemodynamic Monitoring Systems in North America. The Asia-Pacific region is expected to witness the highest growth rate in the forecast period, mainly due to the rapidly aging population in India and China and the high prevalence of diabetes in Vietnam, Singapore, Malaysia, China, and India.

The hemodynamic monitoring systems market is highly competitive, as there are several big and small firms with similar product offerings. These companies adopt various strategies (mergers and acquisitions; agreements, partnerships, collaborations, and joint ventures; new product launches, funding, and FDA approvals; and marketing & promotion) to increase their shares and establish a stronger foothold in the global hemodynamic monitoring systems market.

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn will help them garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares. The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on the product portfolios of the top players in the hemodynamic monitoring systems market. The report analyzes the market based on product, type, , and end user
  • Product Development/Innovation: Detailed insights on upcoming technologies, research and development activities, and new product launches in the hemodynamic monitoring systems market
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various hemodynamic monitoring systems across regions
  • Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the hemodynamic monitoring systems market
  • Competitive Assessment: In-depth assessment of market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the hemodynamic monitoring systems market

TABLE OF CONTENTS

1. INTRODUCTION

  • 1.1. OBJECTIVES OF THE STUDY
  • 1.2. MARKET DEFINITION
  • 1.3. MARKET SCOPE
    • 1.3.1. MARKETS COVERED
    • 1.3.2. YEARS CONSIDERED FOR THE STUDY
  • 1.4. CURRENCY
  • 1.5. LIMITATIONS
  • 1.6. STAKEHOLDERS

2. RESEARCH METHODOLOGY

  • 2.1. RESEARCH METHODOLOGY STEPS
  • 2.2. SECONDARY AND PRIMARY RESEARCH METHODOLOGY
    • 2.2.1. SECONDARY RESEARCH
    • 2.2.2. PRIMARY RESEARCH
      • 2.2.2.1. Key data from primary sources
      • 2.2.2.2. Key insights from primary sources
      • 2.2.2.3. Key industry insights
  • 2.3. MARKET SIZE ESTIMATION METHODOLOGY
  • 2.4. RESEARCH DESIGN
  • 2.5. MARKET DATA VALIDATION AND TRIANGULATION
  • 2.6. ASSUMPTIONS FOR THE STUDY

3. EXECUTIVE SUMMARY

  • 3.1. INTRODUCTION
  • 3.2. CURRENT SCENARIO
  • 3.3. FUTURE OUTLOOK
  • 3.4. CONCLUSION

4. PREMIUM INSIGHTS

  • 4.1. OVERVIEW OF THE HEMODYNAMIC MONITORING SYSTEMS MARKET, (2016-2021)
  • 4.2. HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT
  • 4.3. HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE
  • 4.4. HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER
  • 4.5. GEOGRAPHIC ANALYSIS OF THE HEMODYNAMIC MONITORING SYSTEMS MARKET

5. MARKET OVERVIEW

  • 5.1. INTRODUCTION
  • 5.2. MARKET SEGMENTATION
  • 5.3. MARKET DYNAMICS
    • 5.3.1. DRIVERS
      • 5.3.1.1. Technological advancements in hemodynamic monitoring systems
        • 5.3.1.1.1. Noninvasive hemodynamic monitoring systems
        • 5.3.1.1.2. Micro-Electro-Mechanical Systems (MEMS) technology
      • 5.3.1.2. Increasing initiatives by industry players
      • 5.3.1.3. Rising prevalence of cardiovascular diseases and diabetes
      • 5.3.1.4. Rapid growth in aging population
    • 5.3.2. CHALLENGE
      • 5.3.2.1. Risks associated with invasive hemodynamic monitoring
    • 5.3.3. OPPORTUNITY
      • 5.3.3.1. India and China provide significant market growth opportunities

6. HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT

  • 6.1. INTRODUCTION
  • 6.2. SYSTEMS (MONITORS)
  • 6.3. DISPOSABLES

7. HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE

  • 7.1. INTRODUCTION
  • 7.2. INVASIVE HEMODYNAMIC MONITORING SYSTEMS
  • 7.3. MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS
  • 7.4. NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS

8. HEMODYNAMIC MONITORING SYSTEMS MARKET, BY END USER

  • 8.1. INTRODUCTION
  • 8.2. HOSPITALS
  • 8.3. CATH LABS
  • 8.4. HOME AND AMBULATORY CARE

9. GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION

  • 9.1. INTRODUCTION
  • 9.2. NORTH AMERICA
    • 9.2.1. U.S.
      • 9.2.1.1. Technological advancements in hemodynamic monitoring systems in the U.S.
      • 9.2.1.2. Initiatives adopted by industry players to boost hemodynamic monitoring systems market in U.S.
      • 9.2.1.3. Favorable reimbursement environment likely to drive the hemodynamic monitors market
      • 9.2.1.4. Increasing prevalence of hypertension
      • 9.2.1.5. Growing diabetes prevalence to boost the market for hemodynamic monitoring systems
    • 9.2.2. CANADA
      • 9.2.2.1. Rising usage of heart monitoring systems in Canada
      • 9.2.2.2. High diabetes prevalence to boost the market for hemodynamic monitoring systems
  • 9.3. EUROPE
    • 9.3.1. EUROPE-5
      • 9.3.1.1. Rising prevalence of diabetes and cardiovascular diseases in the U. K.
      • 9.3.1.2. Initiatives adopted by NHS England for the implementation of hemodynamic monitoring systems
      • 9.3.1.3. Conferences on hemodynamic monitoring systems in European countries
      • 9.3.1.4. Active involvement of industry players to augment the demand for hemodynamic monitoring system in Europe-5
      • 9.3.1.5. S3 guidelines for intensive care in cardiac surgeries
      • 9.3.1.6. ODM as a standard of care in France
    • 9.3.2. ROE
      • 9.3.2.1. Hemodynamic monitoring systems gaining momentum in the Netherlands and Sweden
      • 9.3.2.2. High diabetes prevalence in European countries
  • 9.4. ASIA-PACIFIC
    • 9.4.1. JAPAN
      • 9.4.1.1. Active involvement of LiDCO Group plc in Japan
    • 9.4.2. CHINA
      • 9.4.2.1. Company initiatives to enhance product availability in China
      • 9.4.2.2. Rising incidence of diabetes and rapidly aging population
    • 9.4.3. INDIA
      • 9.4.3.1. High Diabetes Prevalence to Accelerate the Market Growth in India
    • 9.4.4. ROAPAC
      • 9.4.4.1. Adoption of hemodynamic monitoring systems in Vietnam, Singapore, & Malaysia
      • 9.4.4.2. Tensys Medical's marketing strategy to bolster the market for noninvasive hemodynamic monitoring in China and Taiwan
      • 9.4.4.3. High diabetes prevalence and rising incidence of CVD in Pacific Countries
  • 9.5. ROW
    • 9.5.1. HIGH DIABETES PREVALENCE IN BRAZIL
    • 9.5.2. LIDCO'S MARKETING STRATEGY TO BOLSTER THE MARKET FOR HEMODYNAMIC MONITORING IN AFRICA
    • 9.5.3. HIGH DIABETES PREVALENCE DRIVING THE ADOPTION OF HEMODYNAMIC MONITORING IN THE MIDDLE EAST & AFRICA

10. COMPETITIVE LANDSCAPE

  • 10.1. OVERVIEW
  • 10.2. COMPETITIVE SITUATION AND TRENDS
  • 10.3. MARKET SHARE ANALYSIS
    • 10.3.1. INTRODUCTION
    • 10.3.2. EDWARDS LIFESCIENCES CORPORATION
    • 10.3.3. PULSION MEDICAL SYSTEMS SE
    • 10.3.4. LIDCO GROUP PLC.
  • 10.4. COMPETITIVE SCENARIO
    • 10.4.1. AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES
    • 10.4.2. PRODUCT LAUNCHES
    • 10.4.3. MERGERS AND ACQUISITIONS
    • 10.4.4. OTHER STRATEGIES

11. COMPANY PROFILES (Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*

  • 11.1. EDWARDS LIFESCIENCES CORPORATION
  • 11.2. PULSION MEDICAL SYSTEMS SE (PART OF THE MAQUET GETINGE GROUP)
  • 11.3. LIDCO GROUP PLC
  • 11.4. CHEETAH MEDICAL, INC.
  • 11.5. DELTEX MEDICAL GROUP PLC
  • 11.6. HEMO SAPIENS, INC.
  • 11.7. ICU MEDICAL, INC.
  • 11.8. OSYPKA MEDICAL GMBH
  • 11.9. SCHWARZER CARDIOTEK GMBH
  • 11.10. TENSYS MEDICAL, INC.

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

12. APPENDIX

  • 12.1. DISCUSSION GUIDE
  • 12.2. COMPANY DEVELOPMENTS (2013-2016)
  • 12.3. KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.4. INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
  • 12.5. AVAILABLE CUSTOMIZATIONS
  • 12.6. RELATED REPORTS

LIST OF TABLES

  • TABLE 1: FEW OF THE DEVELOPMENTS IN THIS REGARD ARE LISTED BELOW:
  • TABLE 2: TOP 5 COUNTRIES WITH THE HIGHEST NUMBER OF DIABETICS (AGED 20-79 YEARS), 2015 VS. 2040
  • TABLE 3: POPULATION AGED 60 YEARS AND OVER, BY REGION (MILLION INDIVIDUALS)
  • TABLE 4: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 5: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 6: TYPES OF HEMODYNAMIC MONITORING SYSTEMS
  • TABLE 7: HEMODYNAMIC MONITORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 8: NORTH AMERICA: HEMODYNAMIC MONITORS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 9: EUROPE: HEMODYNAMIC MONITORS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 10: ASIA-PACIFIC: HEMODYNAMIC MONITORS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 11: TYPES OF DISPOSABLES USED IN HEMODYNAMIC MONITORING
  • TABLE 12: DISPOSABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 13: NORTH AMERICA: HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 14: EUROPE: HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 15: ASIA-PACIFIC: HEMODYNAMIC MONITORING DISPOSABLES MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 16: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 17: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (UNITS)
  • TABLE 18: INVASIVE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 19: NORTH AMERICA: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 20: EUROPE: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 21: ASIA-PACIFIC: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 22: INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012-2019 (UNITS)
  • TABLE 23: MINIMALLY INVASIVE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 24: NORTH AMERICA: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 25: EUROPE: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 26: ASIA-PACIFIC: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY/BY REGION, 2014-2021 (USD MILLION)
  • TABLE 27: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012-2019 (UNITS)
  • TABLE 28: NON INVASIVE MONITORING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 29: NORTH AMERICA: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 30: EUROPE: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 31: ASIA-PACIFIC: NONINVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD THOUSAND)
  • TABLE 32: NON INVASIVE HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2012-2019 (UNITS)
  • TABLE 33: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 34: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR HOSPITALS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 35: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR HOSPITALS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 36: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR HOSPITALS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 37: ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR HOSPITALS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 38: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR CATH LABS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 39: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR CATH LABS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 40: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR CATH LABS, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 41: ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR CATH LABS, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 42: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR HOME AND AMBULATORY CARE, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 43: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR HOME AND AMBULATORY CARE, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 44: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR HOME AND AMBULATORY CARE, BY REGION, 2014-2021 (USD THOUSAND)
  • TABLE 45: ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE FOR HOME AND AMBULATORY CARE, BY COUNTRY, 2014-2021 (USD THOUSAND)
  • TABLE 46: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 47: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY, 2014-2021 (USD MILLION)
  • TABLE 48: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 49: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 50: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 51: U.S.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 52: U.S.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 53: U.S.: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 54: CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 55: CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 56: CANADA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 57: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY REGION, 2014-2021 (USD MILLION)
  • TABLE 58: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 59: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 60: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 61: EUROPE-5: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 62: EUROPE-5: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 63: EUROPE-5: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 64: ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 65: ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 66: ROE: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 67: ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY COUNTRY/REGION, 2014-2021 (USD MILLION)
  • TABLE 68: ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 69: ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 70: ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 71: JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 72: JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD MILLION)
  • TABLE 73: JAPAN: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD MILLION)
  • TABLE 74: CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 75: CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 76: CHINA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 77: INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 78: INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 79: INDIA: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 80: ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 81: ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 82: ROAPAC: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 83: ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY PRODUCT, 2014-2021 (USD MILLION)
  • TABLE 84: ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY TYPE, 2014-2021 (USD THOUSAND)
  • TABLE 85: ROW: HEMODYNAMIC MONITORING SYSTEMS MARKET SIZE, BY END USER, 2014-2021 (USD THOUSAND)
  • TABLE 86: AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES, (2013-2016)
  • TABLE 87: PRODUCT LAUNCHES, (2013-2016)
  • TABLE 88: MERGERS AND ACQUISITIONS, (2013-2016)
  • TABLE 89: OTHER DEVELOPMENTS, 2013-2016

LIST OF FIGURES

  • FIGURE 1: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET SEGMENTATION
  • FIGURE 2: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET: RESEARCH METHODOLOGY
  • FIGURE 3: BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • FIGURE 4: MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
  • FIGURE 5: MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
  • FIGURE 6: RESEARCH DESIGN
  • FIGURE 7: DATA TRIANGULATION METHODOLOGY
  • FIGURE 8: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET ANALYSIS, BY PRODUCT (2016)
  • FIGURE 9: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET ANALYSIS, BY TYPE, 2016 VS. 2021
  • FIGURE 10: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET ANALYSIS, BY END USER, 2016 VS. 2021
  • FIGURE 11: ASIA-PACIFIC MARKET TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 12: ATTRACTIVE OPPORTUNITIES IN THE HEMODYNAMIC MONITORING SYSTEMS MARKET
  • FIGURE 13: DISPOSABLES SEGMENT TO GROW AT THE HIGHEST RATE (2016-2021)
  • FIGURE 14: MINIMALLY INVASIVE HEMODYNAMIC MONITORING SYSTEMS SEGMENT TO WITNESS HIGHEST GROWTH DURING THE FORECAST PERIOD
  • FIGURE 15: HOSPITALS TO COMMAND THE LARGEST SHARE OF THE MARKET IN 2021
  • FIGURE 16: NORTH AMERICA TO DOMINATE THE MARKET
  • FIGURE 17: GLOBAL HEMODYNAMIC MONITORING SYSTEM MARKET SEGMENTATION
  • FIGURE 18: DRIVERS, CHALLENGE, AND OPPORTUNITIES
  • FIGURE 19: PERCENTAGE CHANGE IN POPULATION AGED 60 YEARS AND OVER, BY REGION (2000-2030)
  • FIGURE 20: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY PRODUCT
  • FIGURE 21: GLOBAL HEMODYNAMIC MONITORING SYSTEMS MARKET, BY TYPE, 2016 VS. 2021
  • FIGURE 22: HEMODYNAMIC MONITORING SYSTEMS MARKET SEGMENTATION, BY END USER
  • FIGURE 23: HEMODYNAMIC MONITORING SYSTEMS MARKET, BY REGION, 2016 VS. 2021
  • FIGURE 24: NORTH AMERICA: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 25: EUROPE: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 26: EUROPE: NUMBER OF DIABETICS, BY COUNTRY, 2015 (MILLION CASES)
  • FIGURE 27: ASIA-PACIFIC: HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 28: ROW HEMODYNAMIC MONITORING SYSTEMS MARKET SNAPSHOT
  • FIGURE 29: MAJOR GROWTH STRATEGIES ADOPTED, BY COMPANY
  • FIGURE 30: MARKET SHARE ANALYSIS, BY KEY PLAYER (2015)
  • FIGURE 31: AGREEMENT, COLLABORATION & JOINT VENTURES: THE KEY GROWTH STRATEGIES ADOPTED BY MARKET PLAYERS
  • FIGURE 32: AGREEMENTS, COLLABORATIONS, AND JOINT VENTURES, BY COMPANY (2013-2016) 107  
  • FIGURE 33: PRODUCT LAUNCHES (2013-2016)
  • FIGURE 34: MERGER AND ACQUISITIONS, BY COMPANY (2013-2016)
  • FIGURE 35: OTHER STRATEGIES, BY COMPANY (2013-2016)
  • FIGURE 36: GEOGRAPHIC PRESENCE OF KEY PLAYERS
  • FIGURE 37: EDWARDS LIFESCIENCES CORPORATION: COMPANY SNAPSHOT
  • FIGURE 38: PULSION MEDICAL SYSTEMS SE: COMPANY SNAPSHOT
  • FIGURE 39: LIDCO GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 40: DELTEX MEDICAL GROUP PLC: COMPANY SNAPSHOT
  • FIGURE 41: ICU MEDICAL INC.: COMPANY SNAPSHOT
Back to Top